Cedars-Sinai scientists have developed an experimental drug that repairs DNA and serves as a prototype for a new class of ...

RNA, widely known from the COVID-19 vaccine, is not actually a "therapeutic agent," but a technology that delivers the ...

This year, gene-editing technology was customized to fix mutations in a single patient’s genes for the first time.

Tuberculosis (TB) is one of the oldest and deadliest infectious diseases we know. It commonly impacts the lungs, but can also affect other areas of the body like the spine, brain or kidneys.

Cornell researchers have found that a new DNA sequencing technology can be used to study how transposons move within and bind to the genome. Transposons play critical roles in immune response, ...

A new polymer reported in Nature may mark a turning point for needle-free insulin delivery. Researchers at Zhejiang University have developed a charge-shifting polyzwitterion that can carry insulin ...

Consumers will be able to buy discounted brand-name drugs through a government direct sales exchange called Trump Rx, starting in early 2026. On October 16, the Trump team worked out an agreement with ...

WASHINGTON (TNND) — China has agreed to stop producing and exporting chemicals used to make fentanyl, a breakthrough in the fight against the deadly opioid epidemic, Federal Bureau of Investigation ...

Carpenter is professor of government at Harvard. Hwang is a regulatory policy researcher at Brigham and Women’s Hospital. Kesselheim is professor of medicine at Brigham and Women’s Hospital and ...

GLP-1 is the naturally produced hormone whose function is being mimicked by drugs like semaglutide and tirzepatide, the active ingredients in popular and highly effective weight-loss drugs like Wegovy ...

Joseph Boden receives funding from the New Zealand Ministry of Business, Innovation and Employment, and the Health Research Council of New Zealand. He is affiliated with the Harm Reduction Coalition ...

Scientists inch closer to an autologous diabetes cell therapy that dodges the challenge of immune rejection, creating insulin-producing cells from the lining of the gut. As of 2025, an estimated 9.5 ...